The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Science from our Sisters

Science from our Sisters

April 1, 2007 • By Virginia Hughes

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Model Created for Predicting the Development of RA from UA

Model Created for Predicting the Development of RA from UA

A point-system model that predicts progression of undifferentiated arthritis (UA) to rheumatoid arthritis (RA) using easily measured clinical variables was published in Arthritis & Rheumatism (2007;56(2):433-440).

You Might Also Like
  • Science from our Sisters
  • Science from our Sisters
  • Science from our Sisters
Explore This Issue
April 2007
Also By This Author
  • Catch Some Zs

When patients initially visit a physician because of joint pain, their arthritis is often in the early stages of disease and cannot yet be classified as RA. Of all patients with UA, in fact, only one-third progress to RA.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Early methotrexate treatment can slow progression of RA and prevent joint damage in this patient group. But another 40% to 50% of UA patients eventually go into spontaneous remission, and thus don’t need to be treated with methotrexate, which has side effects including liver toxicity.

“This is a dilemma if you’re trying to achieve the best individual treatment decisions,” says lead author Annette H. M. van der Helm-van Mil, MD, PhD, of Leiden University Medical Center in the Netherlands. “You don’t want to over-treat, but the patients who go on to RA will benefit from early treatment.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The new model is based on data from 570 patients diagnosed with UA between 1993 and 2005. At the initial examination, patients were asked about pain symptoms and severity of any morning stiffness. Blood samples and hand and foot x-rays were taken. After one year, patients were tested again to see if they had progressed to RA.

The researchers performed a multivariate analysis to see how well each of nine clinical variables—gender, age, symptom localization, morning stiffness, tender joint count, swollen joint count, C-reactive protein level, rheumatoid factor positivity, and presence of anti–cyclic citrullinated peptide (anti-CCP) antibodies—predicted RA progression.

The researchers then created a scale ranging from 0 to 14, with different point values assigned for each variable according to how significant it was to predicting RA progression. The most heavily weighted variables are gender, presence of anti-CCP antibodies, and morning stiffness severity.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

The scale had strong predictive ability: 91% of patients who scored a 6 or less on the scale did not progress to RA; 84% of patients that scored an 8 or greater did progress to RA. Clinicians could thus be relatively confident in prescribing medication to a patient scoring above an 8.

But the biggest advantage of such a scale, Dr. van der Helm-van Mil says, is that it “will make it easier for patients to be part of the discussion when the rheumatologist is making a treatment decision.” The researchers are now validating their model in various patient groups throughout Europe.

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Osteoarthritis, Rheumatoid Arthritis Tagged With: Exercise, knee osteoarthritis, Research, Rheumatoid arthritis, riskIssue: April 2007

You Might Also Like:
  • Science from our Sisters
  • Science from our Sisters
  • Science from our Sisters
  • Science from our Sisters

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)